Intestinal Microbiota Mediates the Susceptibility to Polymicrobial Sepsis-Induced Liver Injury by Granisetron Generation in Mice.


Journal

Hepatology (Baltimore, Md.)
ISSN: 1527-3350
Titre abrégé: Hepatology
Pays: United States
ID NLM: 8302946

Informations de publication

Date de publication:
04 2019
Historique:
received: 07 08 2018
accepted: 13 11 2018
pubmed: 7 12 2018
medline: 30 5 2020
entrez: 4 12 2018
Statut: ppublish

Résumé

Sepsis-induced liver injury is recognized as a key problem in intensive care units. The gut microbiota has been touted as an important mediator of liver disease development; however, the precise roles of gut microbiota in regulating sepsis-induced liver injury are unknown. Here, we aimed to investigate the role of the gut microbiota in sepsis-induced liver injury and the underlying mechanism. Cecal ligation and puncture (CLP) was used to induce polymicrobial sepsis and related liver injury. Fecal microbiota transplantation (FMT) was used to validate the roles of gut microbiota in these pathologies. Metabolomics analysis was performed to characterize the metabolic profile differences between sepsis-resistant (Res; survived to 7 days after CLP) and sepsis-sensitive (Sen; moribund before or approximately 24 hours after CLP) mice. Mice gavaged with feces from Sen mice displayed more-severe liver damage than did mice gavaged with feces from Res mice. The gut microbial metabolic profile between Sen and Res mice was different. In particular, the microbiota from Res mice generated more granisetron, a 5-hydroxytryptamine 3 (5-HT

Identifiants

pubmed: 30506577
doi: 10.1002/hep.30361
doi:

Substances chimiques

Cytokines 0
NF-kappa B 0
Receptors, Serotonin, 5-HT3 0
Tlr4 protein, mouse 0
Toll-Like Receptor 4 0
Cyp1a1 protein, mouse EC 1.14.14.1
Cytochrome P-450 CYP1A1 EC 1.14.14.1
Granisetron WZG3J2MCOL

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1751-1767

Subventions

Organisme : Natural Science Funds for Distinguished Young Scholar of Guangdong province
ID : 2016A030306043
Pays : International
Organisme : the funding from State Key Laboratory of Organ Failure Research
ID : 201804
Pays : International
Organisme : NSFC-Guangdong Joint Foundation of China
ID : U1601225
Pays : International
Organisme : Key Scientific and Technological Program of Guangzhou City
ID : 201607020016
Pays : International
Organisme : National Natural Science Foundation of China
ID : 81372030
Pays : International
Organisme : the award of Young Pearl Scholars of Guangdong province
ID : N/A
Pays : International
Organisme : funding from State Key Laboratory of Organ Failure Research
ID : 201804
Pays : International
Organisme : THE award of Young Pearl Scholars of Guangdong province
ID : N/A
Pays : International

Informations de copyright

© 2018 by the American Association for the Study of Liver Diseases.

Auteurs

Shenhai Gong (S)

Department of Intensive Care Unit, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Department of Pathophysiology, Guangdong Provincial Key Laboratory of Proteomics, Southern Medical University, Guangzhou, China.
State Key Laboratory of Organ Failure Research, Southern Medical University, Guangzhou, China.

Zhengzheng Yan (Z)

Department of Pathophysiology, Guangdong Provincial Key Laboratory of Proteomics, Southern Medical University, Guangzhou, China.
State Key Laboratory of Organ Failure Research, Southern Medical University, Guangzhou, China.

Zhanguo Liu (Z)

Department of Intensive Care Unit, Zhujiang Hospital, Southern Medical University, Guangzhou, China.

Mengwei Niu (M)

Department of Pathophysiology, Guangdong Provincial Key Laboratory of Proteomics, Southern Medical University, Guangzhou, China.
State Key Laboratory of Organ Failure Research, Southern Medical University, Guangzhou, China.

Heng Fang (H)

Department of Intensive Care Unit, Zhujiang Hospital, Southern Medical University, Guangzhou, China.

Na Li (N)

Department of Pathophysiology, Guangdong Provincial Key Laboratory of Proteomics, Southern Medical University, Guangzhou, China.
State Key Laboratory of Organ Failure Research, Southern Medical University, Guangzhou, China.

Chenyang Huang (C)

Department of Pathophysiology, Guangdong Provincial Key Laboratory of Proteomics, Southern Medical University, Guangzhou, China.

Lei Li (L)

Department of Pathophysiology, Guangdong Provincial Key Laboratory of Proteomics, Southern Medical University, Guangzhou, China.

Guiming Chen (G)

Department of Pathophysiology, Guangdong Provincial Key Laboratory of Proteomics, Southern Medical University, Guangzhou, China.

Haihua Luo (H)

Department of Pathophysiology, Guangdong Provincial Key Laboratory of Proteomics, Southern Medical University, Guangzhou, China.

Xiaojiao Chen (X)

Division of Laboratory Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Microbiome Medicine Center, Zhujiang Hospital, Southern Medical University, Guangzhou, China.

Hongwei Zhou (H)

State Key Laboratory of Organ Failure Research, Southern Medical University, Guangzhou, China.
Division of Laboratory Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Microbiome Medicine Center, Zhujiang Hospital, Southern Medical University, Guangzhou, China.

Jingjuan Hu (J)

Department of Pathophysiology, Guangdong Provincial Key Laboratory of Proteomics, Southern Medical University, Guangzhou, China.
State Key Laboratory of Organ Failure Research, Southern Medical University, Guangzhou, China.

Wei Yang (W)

Microbiome Medicine Center, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Department of Pathology, Southern Medical University, Guangzhou, China.

Qiaobing Huang (Q)

Department of Pathophysiology, Guangdong Provincial Key Laboratory of Proteomics, Southern Medical University, Guangzhou, China.

Bernd Schnabl (B)

Department of Medicine, University of California San Diego, La Jolla, CA.

Ping Chang (P)

Department of Intensive Care Unit, Zhujiang Hospital, Southern Medical University, Guangzhou, China.

Timothy R Billiar (TR)

Department of Surgery, University of Pittsburgh, Pittsburgh, PA.

Yong Jiang (Y)

Department of Pathophysiology, Guangdong Provincial Key Laboratory of Proteomics, Southern Medical University, Guangzhou, China.
State Key Laboratory of Organ Failure Research, Southern Medical University, Guangzhou, China.

Peng Chen (P)

Department of Intensive Care Unit, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Department of Pathophysiology, Guangdong Provincial Key Laboratory of Proteomics, Southern Medical University, Guangzhou, China.
State Key Laboratory of Organ Failure Research, Southern Medical University, Guangzhou, China.
Microbiome Medicine Center, Zhujiang Hospital, Southern Medical University, Guangzhou, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH